BIOCON
Back to Income Statement
|
BIOCON Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹13,585 Cr | ₹12,243 Cr | ₹11,559 Cr | ₹9,055 Cr | ₹6,691 Cr |
What is the latest Total Expenditure of BIOCON ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹13,585 Cr |
| Mar2025 | ₹12,243 Cr |
| Mar2024 | ₹11,559 Cr |
| Mar2023 | ₹9,055 Cr |
| Mar2022 | ₹6,691 Cr |
How is Total Expenditure of BIOCON Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹13,585 Cr | 10.96 | |
| Mar2025 | ₹12,243 Cr | 5.92 | |
| Mar2024 | ₹11,559 Cr | 27.66 | |
| Mar2023 | ₹9,055 Cr | 35.32 | |
| Mar2022 | ₹6,691 Cr | - | |
Compare Total Expenditure of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹57,210.6 Cr | -2.6% | -10% | -0.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,466.0 Cr | -0.8% | -5.1% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,222.0 Cr | -3.2% | -1.4% | 53.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | -1.6% | -6% | 32.1% | Stock Analytics | |
| CIPLA | ₹107,447.0 Cr | 0% | -3.6% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,471.0 Cr | 3.1% | 8.7% | -1.5% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -2.6% |
-10% |
-0.8% |
| SENSEX | -0.1% |
-2.3% |
-10.7% |
You may also like the below Video Courses